The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

The Global Targeted Sequencing Market is poised for growth due to rising demand for precise diagnostics in genetic disorders ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

OmniAb, Inc. (NASDAQ: OABI) today announced it will hold a virtual investor event to showcase the launch of OmniUltra™ on ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...

The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled ...